TEXERE
Voor TEXERE is een faillissementsprocedure geopend volgens publicaties in het Belgisch Staatsblad. De jaarrekening over 2024 toont een eigen vermogen van €520k en een nettoresultaat van €-480k.
| Eigen vermogen | €520k |
| Netto resultaat | €-480k |
| Werknemers (VTE) | 6,1 |
| Beter dan sector | 51% |
Kwetsbaar profiel, let vooral op gezondheid.
Faillissement geopend
Er loopt al een faillissementsprocedure, een kans-score is dan niet meer zinvol. Bekijk de insolventietijdlijn voor de stand van de procedure.
De volledige opbouw van de score, de scoregeschiedenis per boekjaar en de indicatieve kredietlimiet ontgrendel je met Plus.
Bekijk plannen →| Kengetal | Dit bedrijf | Sectormediaan | Positie in de sector |
|---|---|---|---|
| Solvabiliteit | 67,5% | 66,7% | |
| Nettoresultaat | €-480k | €46k | |
| Eigen vermogen | €520k | €79k | |
| Bruto bedrijfsmarge | €169k | €78k | |
| Personeelskosten | €553k | €21k |
| Boekjaar | 2024 |
|---|---|
| Omzet | - |
| EBITDA | €-407k |
| Nettoresultaat | €-480k |
| Cashflow | €-414k |
| Personeelskosten | €553k |
| Belastingen op het resultaat | €217 |
| Dividenden | - |
| Totaal activa | €771k |
| Eigen vermogen | €520k |
| Schulden | €250k |
| waarvan ≤ 1 jaar | €250k |
| waarvan > 1 jaar | - |
| Werkkapitaal | €356k |
| Werknemers (VTE) | 6,1 |
| 2024 | |
|---|---|
| Current ratio | 2,42 |
| Quick ratio | 0,50 |
| Werkkapitaalratio | 46,2% |
| Solvabiliteit | 67,5% |
| Debt / equity | 0,48 |
| Langetermijnschuldgraad | - |
| Interest coverage | -54,42 |
| Bruto rentabiliteit | - |
| Netto rentabiliteit | - |
| ROA | -62,2% |
| ROE | -92,1% |
| EBITDA-marge | - |
| Klantenkrediet (DSO) | - |
| Leverancierskrediet (DPO) | - |
| Voorraadrotatie | - |
| Voorraaddagen (DSI) | - |
| Post | Code | 2024 |
|---|---|---|
| Balans, Activa | ||
| TOTAAL ACTIVA | 20/58 | €771k |
| Vaste activa | 21/28 | €165k |
| Immateriële vaste activa | 21 | €14 |
| Materiële vaste activa | 22/27 | €165k |
| Vlottende activa | 29/58 | €606k |
| Voorraden en bestellingen in uitvoering | 3 | €482k |
| Vorderingen op ten hoogste één jaar | 40/41 | €28k |
| Liquide middelen | 54/58 | €72k |
| Balans, Passiva | ||
| TOTAAL PASSIVA | 10/49 | €771k |
| Eigen vermogen | 10/15 | €520k |
| Inbreng / kapitaal | 10/11 | €1,00M |
| Overgedragen winst (verlies) | 14 | €-480k |
| Schulden | 17/49 | €250k |
| Schulden op ten hoogste één jaar | 42/48 | €250k |
| Handelsschulden op ten hoogste één jaar | 44 | €98k |
| Resultatenrekening | ||
| Bruto bedrijfsmarge | 9900 | €169k |
| Bedrijfsresultaat | 9901 | €-472k |
| Financiële opbrengsten | 75 | €51 |
| Financiële kosten | 65 | €7k |
| Resultaat vóór belasting | 9903 | €-479k |
| Belastingen op het resultaat | 67/77 | €217 |
| Resultaat van het boekjaar | 9904 | €-480k |
| Te bestemmen resultaat | 9905 | €-480k |
| Rol | Naam | Periode | Bron |
|---|---|---|---|
| Curator | KARL DE RIDDER RUE DU PARC,49, 6000 CHAR-
LEROI- .
Date provisoire de cessation de paiement : 29/06/2026 |
29-06-2026 → heden | Belgisch Staatsblad |
| NACE primair | Gezondheidszorg(86910) |
| Rechtsvorm | NV(014) |
| Oprichtingsdatum | 02-02-2024 |
| Status | Actief |
| Postcode | 6210 |
| Eerste BS-signaal | 03-07-2026 |
| Laatste BS-signaal | 03-07-2026 |
Percelen gekoppeld aan dit bedrijf via zijn adressen in de KBO (zetel, vestigingen, bijkantoren), gekruist met het kadastraal percelenplan. Dit toont waar het bedrijf actief is, geen eigendomsregister.
| Perceel (capakey) | Regio | Oppervlakte | Gebouwen | Hoogte / verd. |
|---|---|---|---|---|
| 52024B0182/00M003 | Wallonië | 5.078 m² | 1 · 686 m² | - |
Eén tijdlijn van alles wat er met dit bedrijf is gebeurd, publicaties, insolventie- en levensloopgebeurtenissen, administratieve wijzigingen en neergelegde jaarrekeningen.
29-08-2025 THERACELL CONSULTING neemt ontslag als bestuurder
- THERACELL CONSULTING, Bestuurder
Technische details
{
"events": [
{
"kind": "director_out",
"role": "administrateur",
"person": {
"rrn": null,
"name": "THERACELL CONSULTING",
"address": null,
"birth_date": null,
"profession": null,
"birth_place": null
},
"reason": "de_plein_droit_dissolution",
"subkind": null,
"via_org": null,
"statutory": "statutair",
"compensated": null,
"effective_date": "2025-08-04",
"evidence_quote": "L\u0027assembl\u00E9e acte, \u00E0 dater de ce jour la d\u00E9mission de la SRL THERACELL CONSULTING de ses fonctions d\u0027administrateur de la soci\u00E9t\u00E9.",
"decharge_status": null,
"mandate_duration": null,
"rep_rotation_new_rep": null,
"rep_rotation_old_rep": null,
"effective_date_qualifier": "immediate"
}
],
"notary": {
"name": "Delphine COGNEAU",
"firm_city": null,
"firm_name": null,
"office_city": null,
"is_associated": false
},
"act_meta": {
"language": "mixed",
"pub_date": "2025-08-29",
"filing_date": "2025-08-21",
"act_kind_objet": "Objet de l\u0027acte:"
},
"decisions": [
{
"body": "algemene_vergadering",
"date": "2025-08-04",
"unanimous": true
}
],
"is_correction": false,
"subject_company": {
"kbo": "1005.576.333",
"name_full": "TEXERE",
"legal_form": "SA"
},
"publication_proxy": {
"kind": "person",
"org_kbo": null,
"org_name": null,
"person_name": "Delphine COGNEAU",
"org_rep_person_name": null,
"person_role_at_subject": "Notaire associ\u00E9e"
},
"co_filed_documents": [],
"corrected_publication_numac": null
}09-10-2024 Verrichting in kapitaal of aandelen
Technische details
{
"events": [],
"notary": {
"name": null,
"firm_city": null,
"firm_name": null,
"office_city": null,
"is_associated": false
},
"act_meta": {
"language": "fr",
"pub_date": "2024-10-09",
"filing_date": "2024-10-07",
"act_kind_objet": "Objet de l\u0027acte :"
},
"decision": {
"body": null,
"act_date": null,
"unanimous": null,
"under_authorized_capital": false,
"underlying_resolution_date": null
},
"bedrijfsrevisor": null,
"subject_company": {
"kbo": "1005.576.333",
"name_full": "TEXERE",
"legal_form": "Soci\u00E9t\u00E9 \u00E0 responsabilit\u00E9 limit\u00E9e",
"is_foreign_registered": false
},
"publication_proxy": {
"kind": "none",
"org_kbo": null,
"org_name": null,
"person_name": null,
"org_rep_person_name": null,
"person_role_at_subject": null
},
"co_filed_documents": [],
"shareholders_after": [],
"share_classes_after": []
}05-07-2024 Kapitaalverhoging van €750.000 tot €750.000
- €0 → €750.000
- Inbreng in geld · Apport en numéraire
Technische details
{
"events": [
{
"kind": "capital_increase",
"after_eur": 750000.0,
"delta_eur": 750000.0,
"before_eur": 0.0,
"subscribers": [
{
"kbo": null,
"rrn": null,
"kind": "person",
"name": "Luc LIEGEOIS",
"share_class": null,
"liberation_pct": null,
"contribution_kind": "geld",
"n_shares_subscribed": 1500,
"contribution_amount_eur": 750000.0
}
],
"_arith_derived": "before",
"share_emission": {
"agio_eur": 250000.0,
"share_form": null,
"share_class": null,
"n_new_shares": 1500,
"with_new_shares": true,
"nominal_value_eur": null,
"issue_price_per_share_eur": 500.0
},
"decrease_purpose": null,
"contribution_type": "geld",
"paid_up_delta_eur": 250000.0,
"n_shares_destroyed": null,
"not_yet_called_eur": 500000.0,
"merger_new_shares_n": null,
"merger_exchange_ratio": null,
"distribution_amount_eur": null,
"statutory_unavailable_equity_op": null
},
{
"kind": "share_class_creation",
"after_eur": null,
"delta_eur": null,
"before_eur": null,
"share_emission": {
"agio_eur": null,
"share_form": null,
"share_class": null,
"n_new_shares": null,
"with_new_shares": false,
"nominal_value_eur": null,
"issue_price_per_share_eur": null
},
"decrease_purpose": null,
"contribution_type": null,
"paid_up_delta_eur": null,
"n_shares_destroyed": null,
"not_yet_called_eur": null,
"merger_new_shares_n": null,
"merger_exchange_ratio": null,
"distribution_amount_eur": null,
"statutory_unavailable_equity_op": null
},
{
"kind": "share_class_creation",
"after_eur": null,
"delta_eur": null,
"before_eur": null,
"share_emission": {
"agio_eur": null,
"share_form": null,
"share_class": null,
"n_new_shares": null,
"with_new_shares": false,
"nominal_value_eur": null,
"issue_price_per_share_eur": null
},
"decrease_purpose": null,
"contribution_type": null,
"paid_up_delta_eur": null,
"n_shares_destroyed": null,
"not_yet_called_eur": null,
"merger_new_shares_n": null,
"merger_exchange_ratio": null,
"distribution_amount_eur": null,
"statutory_unavailable_equity_op": null
}
],
"notary": {
"name": "Gr\u00E9goire Michaux",
"firm_city": null,
"firm_name": null,
"office_city": "Beauvechain",
"is_associated": false
},
"act_meta": {
"language": "fr",
"pub_date": "2024-07-05",
"filing_date": "2024-07-03",
"act_kind_objet": "Objet de l\u0027acte:"
},
"decision": {
"body": "algemene_vergadering",
"act_date": "2024-06-28",
"unanimous": true,
"under_authorized_capital": false,
"underlying_resolution_date": null
},
"bedrijfsrevisor": {
"waived": true,
"firm_kbo": null,
"firm_name": null,
"ibr_number": null,
"mission_type": null,
"individual_name": null
},
"subject_company": {
"kbo": "1005.576.333",
"name_full": "T4.0",
"legal_form": "Soci\u00E9t\u00E9 \u00E0 responsabilit\u00E9 limit\u00E9e",
"is_foreign_registered": false
},
"publication_proxy": {
"kind": "none",
"org_kbo": null,
"org_name": null,
"person_name": null,
"org_rep_person_name": null,
"person_role_at_subject": null
},
"co_filed_documents": [
"Exp\u00E9dition de l\u0027acte",
"Statuts coordonn\u00E9s"
],
"shareholders_after": [
{
"kbo": null,
"pct": null,
"kind": "org",
"name": "SRL THERACELL CONSULTING",
"role": null,
"n_shares": null,
"share_class": null
},
{
"kbo": null,
"pct": null,
"kind": "person",
"name": "Ma\u00EEtre Karl DE RIDDER",
"role": null,
"n_shares": null,
"share_class": null
},
{
"kbo": null,
"pct": null,
"kind": "person",
"name": "Luc LIEGEOIS",
"role": null,
"n_shares": 1500,
"share_class": null
},
{
"kbo": null,
"pct": null,
"kind": "person",
"name": "DUFRANE Denis",
"role": null,
"n_shares": null,
"share_class": null
},
{
"kbo": null,
"pct": null,
"kind": "person",
"name": "LIEGEOIS Luc",
"role": null,
"n_shares": null,
"share_class": null
}
],
"share_classes_after": [
{
"n_shares": 2000,
"class_name": "Gewone Aandelen",
"capital_share_eur": 1000000.0,
"voting_rights_per_share": 1.0
}
]
}Genereer een gestructureerde, feitelijke nota op basis van alle signalen in dit dossier: risico, financiële gezondheid, eigendomsstructuur, mandaten en sectorvergelijking.
| Officiële naamFR | TEXERE |